Purpose: The drug interactions and adverse events that should be considered when individualizing antiemetic therapy for patients undergoing treatment for breast cancer are reviewed. Summary: A ...

Pursuant to section 74 of the Canadian Environmental Protection Act, 1999 (CEPA), the Minister of the Environment and the Minister of Health have conducted a screening assessment of 1,3,5-triazine-2,4 ...

Am J Health Syst Pharm. 2007;64(4):369-381. After assessing a patient s risks, there are three general recommendations a clinician may make (Figure 1): (1) discourage use of the dietary ...